Why Pricing power, R&D, and Scale behave differently in India — and what that implies

One observation has stayed with me for a while now:

I haven’t seen many Indian businesses build themselves by raising prices.

In fact, the opposite seems true.
In India, scale is almost always achieved by lowering prices, expanding reach, and attracting a mass audience. The path to growth runs through affordability, not pricing power.

This creates an immediate tension when we borrow ideas from elsewhere.

In Silicon Valley, investors like Marc Andreessen urge companies to raise prices — not as greed, but as a signal that the product is underpriced, mission-critical, and delivering real value. In China, entire industries scaled behind protection, later monetising dominance to fund deep R&D.

In India, that advice feels counterintuitive — sometimes even impossible.

So the question is worth asking honestly:

Do pricing power, scale, and R&D simply behave differently in India?
And if so, what does that imply for founders, investors, and capital allocators?

Why “raising prices” feels wrong in India

India’s default scaling law is well known:

• The market is large, but extremely price sensitive
• Competition is intense and often fragmented
• Consumers anchor on absolute price, not relative value
• Substitutes appear quickly
• Entry barriers are low and enforcement uneven

In such an environment, raising prices usually invites:

• Immediate customer churn
• Faster imitation
• A race to the bottom

As a result, Indian businesses learn early that:

Scale comes from reach, not ARPU.

This is why most successful Indian companies historically optimised for:

• Cost efficiency
• Distribution
• Working-capital discipline
• Incremental innovation, not frontier R&D

Seen through this lens, Andreessen’s advice feels misplaced. If Indian businesses can’t raise prices, how do they fund R&D? And if they can’t fund R&D, are R&D-heavy businesses simply ruled out in India?

The China contrast — scale first, prices later

China looks superficially similar to India: a large population, price-sensitive consumers, and intense competition.

But economically, it followed a very different path.

China scaled behind protection. India scaled inside competition.

That difference matters.

Chinese businesses were often allowed — sometimes encouraged — to consolidate dominance domestically:

• Limited foreign competition
• State coordination and patient capital
• High tolerance for losses
• Stronger enforcement once scale was achieved

The typical lifecycle looked like this:

1. Subsidised growth and low prices
2. Market dominance and ecosystem lock-in
3. Take-rate increases and monetisation
4. R&D investment and global expansion

In other words:

Pricing power was not the strategy — it was the outcome of power.

India never engineered this phase transition domestically. Regulation, political economy, capital markets, and enforcement all prevented durable dominance from forming at scale.

As a result, most Indian businesses never reached the point where prices could be raised meaningfully without being undercut.

Apple in India — an apparent contradiction

Apple complicates this story.

On the surface, Apple should not work in India:

• Premium pricing
• Minimal localisation
• No attempt to compete on specs or discounts

And yet, Apple has scaled remarkably well.

The key is that Apple did not scale in India the way Indian companies scale.

India was never Apple’s profit engine.
R&D was never funded by Indian margins.
Pricing discipline was imported, not discovered locally.

Apple treated India as:

• A strategic manufacturing base (China+1)
• A premium demand beachhead
• A long-term ecosystem expansion

Several design choices mattered:

• Aspirational positioning rather than mass affordability
• Time-based price discrimination (older models becoming entry premium)
• Financing (EMIs, trade-ins) instead of list-price cuts
• Tight control over distribution and brand enforcement

Apple succeeded in India precisely because it did not behave like an Indian company. Global margins came first; India followed.

This doesn’t break the rule — it reinforces it.

The Indian reality: scale through segmentation, not pricing

The deeper lesson is this:

India does not scale on price. India scales on segmentation.

Indian businesses that have managed to fund R&D or build durable moats usually rely on at least one of the following:

• Exports: R&D paid for by global markets (pharma, IT, SaaS)
• Regulated or compulsory demand: where the user isn’t the payer
• Barbell models: mass adoption on one end, high-margin niches on the other
• Hidden pricing power: better risk engines, lower cost of capital, higher ROE

They rarely raise prices broadly.
Instead, they decouple:

• Where value is created (often India)
• From where value is monetised (often elsewhere or in narrow segments)

This is not a failure of ambition. It is an adaptation to structure.

What this implies — quietly but importantly

A few implications fall out of this way of thinking.

For founders

Trying to fund deep R&D purely from Indian mass pricing is brutally hard. Unless pricing power comes from exports, regulation, or scarcity, the business will be forced into efficiency-led innovation, not frontier bets.

For investors

Businesses that look like they have “pricing power” in India often don’t. True pricing power usually shows up indirectly — in capital efficiency, resilience, and endurance across cycles.

For asset managers and capital allocators

Fee compression is structural. The way forward is not raising headline prices, but pricing discipline, segmentation, capacity control, and alignment with the hardest parts of the value chain — risk, behaviour, and consistency.

A closing thought

Raising prices is not a strategy.
It is a consequence of power.

China engineered power through protection and scale.
The US often does it through IP and platforms.
India, by contrast, has engineered participation.

Understanding this difference matters — not to complain about it, but to design businesses, investment frameworks, and expectations that actually work in the environment we operate in.

The performance-related information provided in this newsletter/blog is not verified by SEBI. The content is intended solely for internal circulation and general informational purposes. It does not constitute investment advice or any form of financial recommendation.

The research information shared herein may contain inaccuracies or typographical errors. All liability for actions taken or not taken based on the content of this newsletter/blog is expressly disclaimed.

No reader, user, or browser of this Newsletter / blog should act or refrain from acting based on any information in this newsletter/blog without seeking independent financial advice. Use of, and access to, this publication or any links or resources provided within do not establish a portfolio manager-client relationship between the reader, user, or browser and the authors, contributors or Itus Capital.